albuterol has been researched along with Central Core Disease in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this pilot study was to evaluate the effect of the beta2-agonist salbutamol (albuterol) in a group of children with central core disease and multi-minicore disease." | 5.11 | Pilot trial of salbutamol in central core and multi-minicore diseases. ( Hartley, L; Jungbluth, H; Kinali, M; Main, M; Mercuri, E; Messina, S; Muntoni, F, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schreuder, LT | 1 |
| Nijhuis-van der Sanden, MW | 1 |
| de Hair, A | 1 |
| Peters, G | 1 |
| Wortmann, S | 1 |
| Bok, LA | 1 |
| Morava, E | 1 |
| Messina, S | 1 |
| Hartley, L | 1 |
| Main, M | 1 |
| Kinali, M | 1 |
| Jungbluth, H | 1 |
| Muntoni, F | 1 |
| Mercuri, E | 1 |
1 trial available for albuterol and Central Core Disease
| Article | Year |
|---|---|
Pilot trial of salbutamol in central core and multi-minicore diseases.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Child; Child, Preschool; Cohort Studies; Dru | 2004 |
1 other study available for albuterol and Central Core Disease
| Article | Year |
|---|---|
Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction.
Topics: Activities of Daily Living; Adrenergic beta-2 Receptor Agonists; Albuterol; Child; Combined Modality | 2010 |